seed
Stage
1
Investors
About
Neurocentrx Pharma develops oral ketamine formulations and digital prescription software to provide safer, accessible treatments for major mental health conditions, focusing on treatment-resistant major depressive disorder and bipolar depression.
Explore Neurocentrx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.